384 related articles for article (PubMed ID: 32836055)
21. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
Lasota J; Miettinen M
Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355
[TBL] [Abstract][Full Text] [Related]
22. Somatic mutational spectrum analysis in a prospective series of 104 gastrointestinal stromal tumors.
Guenat D; Deroo O; Magnin S; Chaigneau L; Monnien F; Borg C; Mougin C; Emile JF; Prétet JL
Oncol Rep; 2017 Mar; 37(3):1671-1681. PubMed ID: 28098915
[TBL] [Abstract][Full Text] [Related]
23. Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs.
Emile JF; Brahimi S; Coindre JM; Bringuier PP; Monges G; Samb P; Doucet L; Hostein I; Landi B; Buisine MP; Neuville A; Bouché O; Cervera P; Pretet JL; Tisserand J; Gauthier A; Le Cesne A; Sabourin JC; Scoazec JY; Bonvalot S; Corless CL; Heinrich MC; Blay JY; Aegerter P
Med Oncol; 2012 Sep; 29(3):1765-72. PubMed ID: 21953054
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM
Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765
[TBL] [Abstract][Full Text] [Related]
25. Pathological characteristics of gastrointestinal stromal tumours with PDGFRA mutations.
Kwon JE; Kang HJ; Kim SH; Lee YC; Hyung WJ; Noh SH; Kim NK; Kim H
Pathology; 2009; 41(6):544-54. PubMed ID: 19900103
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
27. Identifying Secondary Mutations in Chinese Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs) by Next Generation Sequencing (NGS).
Du J; Wang S; Wang R; Wang SY; Han Q; Xu HT; Yang P; Liu Y
Pathol Oncol Res; 2020 Jan; 26(1):91-100. PubMed ID: 31758409
[TBL] [Abstract][Full Text] [Related]
28. Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors.
Nishida T; Naito Y; Takahashi T; Saito T; Hisamori S; Manaka D; Ogawa K; Hirota S; Ichikawa H
Cancer Sci; 2024 Mar; 115(3):894-904. PubMed ID: 38178783
[TBL] [Abstract][Full Text] [Related]
29. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
[TBL] [Abstract][Full Text] [Related]
30. [Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs].
Kalfusová A; Kodet R
Cesk Patol; 2017; 53(4):167-173. PubMed ID: 29227120
[TBL] [Abstract][Full Text] [Related]
31. Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors?
Patil DT; Rubin BP
Surg Pathol Clin; 2015 Sep; 8(3):515-24. PubMed ID: 26297068
[TBL] [Abstract][Full Text] [Related]
32. Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.
Joensuu H; Wardelmann E; Sihto H; Eriksson M; Sundby Hall K; Reichardt A; Hartmann JT; Pink D; Cameron S; Hohenberger P; Al-Batran SE; Schlemmer M; Bauer S; Nilsson B; Kallio R; Junnila J; Vehtari A; Reichardt P
JAMA Oncol; 2017 May; 3(5):602-609. PubMed ID: 28334365
[TBL] [Abstract][Full Text] [Related]
33. Microscopic gastrointestinal stromal tumours: a clinical and molecular study of 13 cases.
Anderson W; O'Sullivan B; Hughes F; Swift C; Smith M; Deshmukh N; Taniere P
Histopathology; 2017 Jan; 70(2):211-216. PubMed ID: 27472829
[TBL] [Abstract][Full Text] [Related]
34. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.
Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G
J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417
[TBL] [Abstract][Full Text] [Related]
35. KIT and BRAF heterogeneous mutations in gastrointestinal stromal tumors after secondary imatinib resistance.
Zheng S; Huang KE; Pan YL; Zhou Y; Pan SD; Li X; Jia J; Zheng XL; Tao DY
Gastric Cancer; 2015 Oct; 18(4):796-802. PubMed ID: 25182956
[TBL] [Abstract][Full Text] [Related]
36. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).
Nannini M; Biasco G; Astolfi A; Pantaleo MA
J Med Genet; 2013 Oct; 50(10):653-61. PubMed ID: 23833252
[TBL] [Abstract][Full Text] [Related]
37. Malignancies associated with GIST: a retrospective study with molecular analysis of KIT and PDGFRA.
Mayr P; Märkl B; Agaimy A; Kriening B; Dintner S; Schenkirsch G; Schneider-Stock R
Langenbecks Arch Surg; 2019 Aug; 404(5):605-613. PubMed ID: 30877378
[TBL] [Abstract][Full Text] [Related]
38. Mutational profile of KIT and PDGFRA genes in gastrointestinal stromal tumors in Peruvian samples.
Buleje J; Acosta Ó; Guevara-Fujita M; Enriquez Y; Taxa L; Machicado E; Lizaraso-Caparó F; Fujita R
Rev Esp Enferm Dig; 2015 Feb; 107(2):72-8. PubMed ID: 25659388
[TBL] [Abstract][Full Text] [Related]
39. Detection of KIT and PDGFRA mutations in the plasma of patients with gastrointestinal stromal tumor.
Kang G; Bae BN; Sohn BS; Pyo JS; Kang GH; Kim KM
Target Oncol; 2015 Dec; 10(4):597-601. PubMed ID: 25735500
[TBL] [Abstract][Full Text] [Related]
40. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
